Zero Gravity Solutions, Inc. Announces Publication of Important Research Article in the International Journal of Biochemistry Research and Review | Business

BOCA RATON, Fla.–(BUSINESS WIRE)–January 26, 2022–

Zero Gravity Solutions, Inc. (“ZGSI” or the “Company”) (Pink Sheets: ZGSI ), an agricultural biotechnology company, announced that the International Journal of Research and Examination in Biochemistry published a peer-reviewed research paper describing the mechanism by which the Company’s technology activates the innate defenses of plants against disease. In this illustrative case study, the Company identified novel plant biomarkers expressed when a plant experiences fungal attack and demonstrated how our technology successfully triggers plants’ natural fungal defenses, a response known as priming. The results validate the technology’s mode of action and pave the way for the company to expand its product line with proprietary priming elicitors that enable plants to sustainably increase yield and protect against disease.

“Identifying the molecular mechanism of BAM initiation and the specific biomarkers it induces is a scientific breakthrough for the Company. Our research validates our theory that a plant’s natural defenses are triggered by the company’s priming technology,” said Dr Ravi Pottathil, scientific director of Zero Gravity Solutions. “We believe that the next generation of sustainable agricultural solutions will come from seed applications. We intend to introduce new elicitor formulations as part of our seed technology platform in the near future based on the biomarkers we have identified.

The Company expects the use of seed technologies to be the next category of agricultural product innovation to achieve green and sustainable agricultural practices. Of the society technology platformwhich has been validated by numerous third-party trials both nationally and internationally, is at the forefront of an expected increasing use of initiators as powerful tools for mitigating plant diseases.

“The results of our recent research, combined with the continued commercial success of our BAM-FX product, reinforces our position that our priming technology is a cutting-edge innovation that will continue to make a strong contribution to the tools a grower has to naturally stimulate the biological potential of their crops,” said Timothy Peach, CEO/CFO of Zero Gravity Solutions, Inc.

The referenced published research paper is available at:

About Zero Gravity Solutions, Inc.

Zero Gravity Solutions, Inc. is a public agricultural biotechnology company with technology derived and designed for space with significant applications here on Earth. These technologies aim to provide valuable solutions to the challenges facing global agriculture. Marketing activities are carried out by ZGSI’s two operating subsidiaries, BAM Agricultural Solutions, Inc. and Specialty Agricultural Solutions, Inc.

This press release may contain certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Investors are cautioned that these forward-looking statements involve risks and uncertainties, including, without limitation, acceptance of the Company’s products, increased levels of competition for the Company, new products and changes in technology, the Company’s dependence on third-party suppliers and other risks. detailed from time to time in the Company’s periodic reports filed with the Securities and Exchange Commission. Except as required by applicable law or regulation, Zero Gravity Solutions undertakes no obligation to update these forward-looking statements to reflect events or circumstances that occur after the date on which these statements were made.

Show source version on

CONTACT: Zero Gravity Solutions, Inc.

Julie Bloch, VP Communications

+1 561.416.0400

[email protected]



SOURCE: Zero Gravity Solutions, Inc.

Copyright BusinessWire 2022.

PUBLISHED: 01/26/2022 10:14 AM/DISC: 01/26/2022 10:14 AM

Copyright BusinessWire 2022.

Comments are closed.